ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.87
0.00%
US Tech 100
16,772.00
0.11%
S&P 500
5,010.60
0.87%
US Dollar vs CAD
1.37021
0.01%
Bitcoin
66,086.85
-1.15%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN AstraZeneca PLC

70.31
0.18 (0.26%)
Pre Market
Last Updated: 07:15:20
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AstraZeneca PLC AZN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.18 0.26% 70.31 07:15:20
Open Price Low Price High Price Close Price Previous Close
70.13
more quote information »

Recent News

Date Time Source Heading
4/16/202406:00BWIMFINZI® (durvalumab) plus chemotherapy doubled overall..
4/12/202406:05IHMARKETNEWSParamount Global Board Shrinks, Morgan Stanley Faces..
4/11/202406:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
4/11/202406:00BWFASENRA approved for treatment of children aged 6 to 11 with..
4/05/202422:10BWENHERTU® Approved in the U.S. as First Tumor Agnostic HER2..
4/05/202420:43BWENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the..
4/05/202406:00BWIMFINZI® (durvalumab) significantly improved overall..
4/02/202406:00BWDatopotamab deruxtecan Biologics License Application..
4/02/202401:00BWDatopotamab Deruxtecan Biologics License Application..
4/01/202406:00BWVOYDEYA™ approved in the US as add-on therapy to ravulizumab..
3/27/202405:54IHMARKETNEWSGameStop Shares Tumble 20% in Pre-Market Trading Amid..
3/26/202406:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
3/25/202406:00BWULTOMIRIS® (ravulizumab-cwvz) approved in the US for the..
3/19/202406:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
3/19/202406:00BWAstraZeneca to acquire Fusion to accelerate the development..
3/19/202405:52IHMARKETNEWSAstraZeneca to acquire Fusion for $2 billion
3/18/202406:00BWAstraZeneca caps patient out-of-pocket costs at $35 per..
3/14/202406:39IHMARKETNEWSFisker’s Shares Take a Hit Amid Speculation of Bankruptcy,..
3/13/202406:06BWAstraZeneca announces initiation of THARROS – a Phase III..
3/07/202404:43IHMARKETNEWSTesla Exits Market Top 10, Victoria’s Secret Stock Tumbles..
2/26/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/26/202408:00PRNCAAlexion Canada donne de la couleur aux maladies rares avec..
2/26/202405:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/202415:09EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2/23/202412:23BWMANDARA Phase III data published in New England Journal of..
2/22/202408:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/22/202408:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/19/202406:10BWDatopotamab deruxtecan Biologics License Application..
2/19/202406:05BWTAGRISSO® (osimertinib) demonstrated overwhelming efficacy..
2/19/202401:00BWDatopotamab Deruxtecan Biologics License Application..
2/16/202421:00BWTAGRISSO® (osimertinib) with the addition of chemotherapy..
2/09/202404:51IHMARKETNEWSCloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14%..
2/08/202405:10IHMARKETNEWSArm Achieves Record Revenue, PayPal Shares Plummet by More..
2/08/202401:03BWAstraZeneca Full year and Q4 2023 Financial Results
2/07/202406:31PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
2/07/202405:51PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
2/06/202408:00BWAstraZeneca expands US manufacturing footprint to accelerate..
2/05/202408:00GLOBEYiviva Announces Memorandum of Understanding with..
1/29/202406:00BWENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority..
1/24/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202406:00BWAIRSUPRA® (albuterol/budesonide) now available as the first..
1/19/202409:05BWIMFINZI® (durvalumab) plus transarterial chemoembolization..
1/19/202407:46EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
1/19/202407:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/16/202405:15IHMARKETNEWSWall Street Highlights: Apple Cuts iPhone Prices in China,..
1/08/202407:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..
1/08/202406:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
1/03/202403:25DJNC4X Discovery Shares Rise on AstraZeneca Milestone Payment
1/02/202409:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/02/202408:00PRNUSAllorion Therapeutics Announces Exclusive Option and Global..

Your Recent History

NASDAQ
AZN
AstraZeneca
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved